 |
PDBsum entry 1tyr
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Retinol-binding
|
PDB id
|
|
|
|
1tyr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Eur J Biochem
234:563-569
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the transthyretin--retinoic-acid complex.
|
|
G.Zanotti,
M.R.D'Acunto,
G.Malpeli,
C.Folli,
R.Berni.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Retinoids are quite insoluble and chemically unstable compounds in the aqueous
medium, such that natural retinoids need to be bound to specific
retinoid-binding proteins to be protected, solubilized and transported in body
fluids. All-trans retinoic acid exhibits a relatively high affinity for
thyroxine-binding transthyretin in vitro and this protein is a good candidate
for the transport of retinoic acid administered as pharmacological or antitumor
agent. To define structural features essential for the recognition by
transthyretin of a ligand which is structurally unrelated to thyroxine, we have
cocrystallized human transthyretin with retinoic acid and determined its
structure at 0.18-nm resolution. The retinoid fits into the two chemically
identical thyroxine-binding sites, which are located in the central channel that
runs through the tetrameric transthyretin. The cyclohexene ring of the bound
retinoid is innermost, occupying the same position of the phenolic ring of the
bound 3,3'-diiodo-L-thyronine, whereas the carboxylate group, like the same
group of the thyroid hormone, participates in an ionic interaction with the
Lys15 side chain at the entrance of the channel. Despite the fact that
transthyretin was cocrystallized with all-trans-retinoic acid, the isoprene
chain of the bound retinoid has been found in a non-extended conformation. This
feature, that allows the carboxylate to orient in a manner suitable for ion-pair
association with the Lys15 side chain, is attributable to the conversion of
all-trans-retinoic acid into cis-isomers or folded conformers. It is concluded
that the presence, in an essentially hydrophobic molecular core of the
appropriate size, of a negatively charged group at the correct position is a
crucial requirement for ligand-transthyretin recognition. Whereas the binding of
the ligand has no remarkable consequences for the protein structure,
all-trans-retinoic acid undergoes structural changes such as to interact
favorably with residues present in the thyroxine-binding sites, resembling
roughly the natural ligand.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Connelly,
S.Choi,
S.M.Johnson,
J.W.Kelly,
and
I.A.Wilson
(2010).
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.
|
| |
Curr Opin Struct Biol,
20,
54-62.
|
 |
|
|
|
|
 |
S.K.Palaninathan,
N.N.Mohamedmohaideen,
E.Orlandini,
G.Ortore,
S.Nencetti,
A.Lapucci,
A.Rossello,
J.S.Freundlich,
and
J.C.Sacchettini
(2009).
Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.
|
| |
PLoS One,
4,
e6290.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Ramazzina,
C.Folli,
A.Secchi,
R.Berni,
and
R.Percudani
(2006).
Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes.
|
| |
Nat Chem Biol,
2,
144-148.
|
 |
|
|
|
|
 |
M.R.Almeida,
A.M.Damas,
M.C.Lans,
A.Brouwer,
and
M.J.Saraiva
(1997).
Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
|
| |
Endocrine,
6,
309-315.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |